CA2350753A1 - Benzylmaltosides as inhibitors of smooth muscle cell proliferation - Google Patents

Benzylmaltosides as inhibitors of smooth muscle cell proliferation Download PDF

Info

Publication number
CA2350753A1
CA2350753A1 CA002350753A CA2350753A CA2350753A1 CA 2350753 A1 CA2350753 A1 CA 2350753A1 CA 002350753 A CA002350753 A CA 002350753A CA 2350753 A CA2350753 A CA 2350753A CA 2350753 A1 CA2350753 A1 CA 2350753A1
Authority
CA
Canada
Prior art keywords
carbon atoms
hydrogen
alkyl
perfluoroalkyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002350753A
Other languages
English (en)
French (fr)
Inventor
Paul Jeffrey Dollings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2350753A1 publication Critical patent/CA2350753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002350753A 1998-11-24 1999-11-23 Benzylmaltosides as inhibitors of smooth muscle cell proliferation Abandoned CA2350753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19843498A 1998-11-24 1998-11-24
US09/198,434 1998-11-24
PCT/US1999/027824 WO2000031100A2 (en) 1998-11-24 1999-11-23 Benzylmaltosides as inhibitors of smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
CA2350753A1 true CA2350753A1 (en) 2000-06-02

Family

ID=22733369

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002350753A Abandoned CA2350753A1 (en) 1998-11-24 1999-11-23 Benzylmaltosides as inhibitors of smooth muscle cell proliferation

Country Status (7)

Country Link
EP (1) EP1133512A2 (de)
JP (1) JP2002530424A (de)
CN (1) CN1333784A (de)
AU (1) AU1743900A (de)
BR (1) BR9915571A (de)
CA (1) CA2350753A1 (de)
WO (1) WO2000031100A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1133510A2 (de) * 1998-11-24 2001-09-19 American Home Products Corporation Acylierte benzylmaltoside als inhibitoren der proliferation von muskelzellen
CN105367614B (zh) * 2015-11-24 2019-02-22 中国人民解放军第二军医大学 含有葡萄糖类脂肪酸衍生物的制备方法及其在医药领域的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them
CN1348460A (zh) * 1998-11-24 2002-05-08 美国家用产品公司 作为平滑肌细胞增殖抑制剂的缩醛苄基麦芽糖苷类

Also Published As

Publication number Publication date
CN1333784A (zh) 2002-01-30
WO2000031100A2 (en) 2000-06-02
BR9915571A (pt) 2001-08-14
WO2000031100A3 (en) 2000-11-23
EP1133512A2 (de) 2001-09-19
AU1743900A (en) 2000-06-13
JP2002530424A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
CA2350753A1 (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6187755B1 (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6339064B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6451767B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6291434B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2350755A1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6340670B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2351060A1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US7132402B2 (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2351059A1 (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2350759A1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
WO2000031093A2 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6664243B1 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US20040092457A1 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
MXPA01005178A (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2350066A1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
CA2351061A1 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
MXPA01005171A (es) Bencilglicosilamidas como inhibidores de la proliferacion de celulas de musculoliso
MXPA01005174A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005173A (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation

Legal Events

Date Code Title Description
FZDE Dead